Priority Date: 13.04.10 (EP 20100159825)

COMBINATION OF A MACROCYCLIC INHIBITOR OF HCV, A NON-NUCLEOSIDE AND A NUCLEOSIDE

  • Application ID: EP11715219
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Janssen Pharmaceutica N.V. is specialized in A61. Janssen Pharmaceutica N.V. is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 13.04.2010 - Priority Date (EP 20100159825)
  • 20.10.2011 - Publication A1 (WO2011128378)
  • 20.02.2013 - Publication A1 (EP2558091)